2:01 PM
 | 
Jan 02, 2018
 |  BC Innovations  |  Distillery Therapeutics

Hepatic

INDICATION: Hepatic

Patient sample, mouse, pig and macaque studies suggest inhibiting ALOX12 could help treat ischemia/reperfusion-induced liver injury. In liver samples from hepatocellular carcinoma (HCC) or hepatic cyst patients undergoing surgical liver resection, levels of ALOX12 were higher during...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >